Merck wins appeal on first Vioxx case
NEW YORK (Reuters) - A Texas appeals court on Thursday reversed a $26.1 million decision against Merck & Co, finding that its withdrawn Vioxx painkiller did not cause the fatal heart attack suffered by a plaintiff's husband.
<p><img src="http://feeds.feedburner.com/~a/reuters/healthNews?i=z54Nuz" border="0"></img> (http://feeds.feedburner.com/~a/reuters/healthNews?a=z54Nuz)</p><div class="feedflare">
<img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=kDSUoH" border="0"></img> (http://feeds.feedburner.com/~f/reuters/healthNews?a=kDSUoH) <img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=qvdexh" border="0"></img> (http://feeds.feedburner.com/~f/reuters/healthNews?a=qvdexh) <img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=tSmBOh" border="0"></img> (http://feeds.feedburner.com/~f/reuters/healthNews?a=tSmBOh)
</div><img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/300594528" height="1" width="1"/>
http://feeds.feedburner.com/~r/reuters/healthNews/~3/300594528/idUSN2945701220080529